Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$6.29 - $15.72 $39,727 - $99,287
6,316 Added 23.22%
33,511 $411,000
Q3 2023

Nov 02, 2023

BUY
$14.99 - $32.65 $90,569 - $197,271
6,042 Added 28.56%
27,195 $407,000
Q2 2023

Aug 07, 2023

BUY
$29.76 - $46.14 $156,091 - $242,004
5,245 Added 32.97%
21,153 $687,000
Q1 2023

May 09, 2023

SELL
$38.09 - $57.79 $4.29 Million - $6.5 Million
-112,525 Reduced 87.61%
15,908 $622,000
Q4 2022

Feb 09, 2023

BUY
$40.54 - $56.2 $4.64 Million - $6.44 Million
114,561 Added 825.84%
128,433 $6.79 Million
Q3 2022

Nov 09, 2022

SELL
$36.98 - $49.2 $318,952 - $424,350
-8,625 Reduced 38.34%
13,872 $624,000
Q2 2022

Aug 10, 2022

SELL
$28.03 - $45.8 $104,832 - $171,292
-3,740 Reduced 14.25%
22,497 $818,000
Q1 2022

May 09, 2022

SELL
$29.24 - $44.06 $235,791 - $355,299
-8,064 Reduced 23.51%
26,237 $1.08 Million
Q4 2021

Feb 09, 2022

SELL
$39.32 - $61.61 $1.45 Million - $2.28 Million
-36,955 Reduced 51.86%
34,301 $1.46 Million
Q3 2021

Nov 09, 2021

BUY
$44.0 - $65.8 $112,464 - $168,184
2,556 Added 3.72%
71,256 $3.92 Million
Q2 2021

Aug 10, 2021

BUY
$44.66 - $63.06 $955,009 - $1.35 Million
21,384 Added 45.19%
68,700 $3.29 Million
Q1 2021

May 10, 2021

BUY
$46.31 - $62.7 $92,666 - $125,462
2,001 Added 4.42%
47,316 $2.4 Million
Q4 2020

Feb 08, 2021

SELL
$55.51 - $69.94 $37,913 - $47,769
-683 Reduced 1.48%
45,315 $2.85 Million
Q3 2020

Nov 06, 2020

BUY
$42.19 - $69.61 $673,478 - $1.11 Million
15,963 Added 53.15%
45,998 $3.09 Million
Q2 2020

Aug 05, 2020

BUY
$27.55 - $43.28 $827,464 - $1.3 Million
30,035 New
30,035 $1.26 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.